MED
Medifast, Inc. · NYSE · Consumer Cyclical · USD · 10-K for 2025, filed 2026-02-17
Figures on this page computed 2026-11-08 13:24 UTC
Last close
13.15USD
Market data, 2026-11-04
Weekly closes, 2026-08-14 to 2026-11-04
Over that span: +14.9%
Except where said otherwise: 10-K for 2025, filed 2026-02-17
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-17
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
-4.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
0.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
0.05Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
0.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.04 against 0.44 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-17
- Sales0.49x
Its own average over 10 years, 791.1M.
- Profit-0.28x
Its own average over 10 years, 67.3M.
- Free cash flow0.02x
Its own average over 10 years, 73.0M.
- Debt1.10x
Its own average over 5 years, 9.8M.
- Price0.13x
Its own average over 11 years, 98. Market data, 2026-11-04
Profit is furthest from its own average, at -0.28 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 109.8 | 155.4 | 101.2 |
| 2018-12-31 | 182.5 | 312.8 | 101.1 |
| 2019-12-31 | 260.0 | 436.9 | 101.4 |
| 2020-12-31 | 340.5 | 576.7 | 99.2 |
| 2021-12-31 | 555.9 | 919.7 | 98.9 |
| 2022-12-31 | 582.3 | 805.0 | 94.4 |
| 2023-12-31 | 390.5 | 557.4 | 91.4 |
| 2024-12-31 | 219.4 | 11.7 | 91.8 |
| 2025-12-31 | 140.5 | -104.7 | 91.9 |
How sales was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
Figures behind the shape
Growth
-16.2%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate-16.2%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income-993.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
-9.4%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
Return on equity-9.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
Return on assets-7.5%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
Margins
71.3%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin71.3%
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Operating margin-3.7%
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Net margin-4.8%
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Free cash flow margin0.3%
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Price
0.7xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-17
Price to book0.7x10-Q for 2025, filed 2026-10-26
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-067165
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-10-26
- computed
- 10-K for 2025, filed 2026-02-17
EV to EBITDA2139.9x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
- 10-K for 2025, filed 2026-02-17
Price to sales ratio0.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Safety
0.05safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.05
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
Current ratio4.6910-Q for 2025, filed 2026-10-26
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-067165
- Reported in
- USD
- 10-Q for 2025, filed 2026-10-26
- 10-Q for 2025, filed 2026-10-26
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Altman Z-Score4.75
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-02-17
- Computed from the 10-K for 2025, filed 2026-02-17
- Computed from the 10-K for 2025, filed 2026-02-17
- Computed from the 10-K for 2025, filed 2026-02-17
- Computed from the 10-K for 2025, filed 2026-02-17
What it pays out
0.1%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield0.1%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- Computed from the 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
Dividend cover ratio6.4x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.